Passage Bio
Susan Browne has an extensive background in neuroscience and pharmacology, with experience in leading research and development teams in the pharmaceutical industry. Susan has held various roles in academia and industry, focusing on drug discovery and development for CNS disorders such as Parkinson's disease, Huntington's disease, Alzheimer's disease, and psychiatric disorders. With a strong foundation in neurobiology, Susan has led translational research efforts and built discovery pipelines aimed at developing therapeutics for neurodegenerative diseases and other CNS disorders. Currently serving as Senior Vice President of Research & Development at Passage Bio, Susan brings a wealth of knowledge and expertise to the field.
This person is not in the org chart
Passage Bio
1 followers
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).